Artivion Inc Quick Ratio (AORT) starting from the first quarter 2026 to first quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Artivion Inc   (NYSE: AORT)

Artivion Inc 's Quick Ratio

AORT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the first quarter 2026, Quick Ratio deteriorated to 0.6 below Artivion Inc 's average Quick Ratio.

Within Medical Equipment & Supplies industry 124 other companies have achieved higher Quick Ratio than Artivion Inc in first quarter 2026. While Quick Ratio total ranking in the first quarter 2026 has deteriorated compared to the prior quarter from 1319 to 2063.

Explain Quick Ratio?
How much Cash & cash equivalents AORT´s has?
What are AORT´s Current Liabilities?




AORT Quick Ratio (Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
(Mar 31 2025)
Q1
Y / Y Current Liabilities Change 78.48 % 51.98 % -43.84 % 31.81 % 13.33 %
Y / Y Cash & cash equivalent Change 47.94 % 21.41 % 30.71 % -2.8 % -26.26 %
Quick Ratio MRQ 0.6 0.64 0.86 0.8 0.73
AORT's Total Ranking # 2063 # 1319 # 1693 # 1618 # 1825
Seq. Current Liabilities Change -8.72 % 18.31 % 28.75 % 28.36 % -22.27 %
Seq. Cash & cash equivalent Change -14.09 % -11.6 % 37.31 % 41.87 % -29.5 %



Quick Ratio first quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 125
Healthcare Sector # 673
Overall Market # 2063


Quick Ratio Statistics
High Average Low
2.88 1.38 0.37
(Mar 31 2014)   (Sep 30 2024)




Financial Statements
Artivion Inc 's Current Liabilities $ 93 Millions Visit AORT's Balance sheet
Artivion Inc 's Cash & cash equivalent $ 56 Millions Visit AORT's Balance sheet
Source of AORT's Sales Visit AORT's Sales by Geography


Cumulative Artivion Inc 's Quick Ratio

AORT's Quick Ratio for the trailling 12 Months

AORT Quick Ratio

(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
(Mar 31 2025)
12 Months
Y / Y Current Liabilities TTM Growth 7.63 % -3.19 % -11.96 % 60.91 % 49.25 %
Y / Y Cash & cash equivalent TTM Growth 22.35 % 6.36 % -1.44 % -8.12 % -4.69 %
Quick Ratio TTM 0.71 0.75 0.8 0.59 0.63
Total Ranking TTM # 3139 # 2091 # 3216 # 3055 # 3256
Seq. Current Liabilities TTM Growth 13.32 % 12.8 % -19.81 % 4.99 % 1.93 %
Seq. Cash & cash equivalent TTM Growth 7.87 % 5.25 % 8.59 % -0.76 % -6.22 %


On the trailing twelve months basis Due to decrease in Current Liabilities in the Q1 2026 to $92.70 millions, cumulative Quick Ratio decreased to 0.71 below the Artivion Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 180 other companies have achieved higher Quick Ratio than Artivion Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2025 from 2091 to 3139.

Explain Quick Ratio?
How much Cash & cash equivalents AORT´s has?
What are AORT´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 181
Healthcare Sector # 831
Within the Market # 3139


trailing twelve months Quick Ratio Statistics
High Average Low
1.1 0.86 0.59
(Mar 31 2022)   (Jun 30 2025)




Companies with similar Quick Ratio in the quarter ending Mar 31 2026, within Medical Equipment & Supplies Industry Quick RatioMar 31 2026 MRQ Cash & cash equivalentMar 31 2026 MRQ Current Liabilities
Axe Compute Inc  1.64 $ 6.925  Millions$ 4.227  Millions
Si bone inc   1.61 $ 33.535  Millions$ 20.829  Millions
Nephros Inc   1.59 $ 4.018  Millions$ 2.527  Millions
Logicmark Inc  1.55 $ 2.110  Millions$ 1.361  Millions
Adagio Medical Holdings inc   1.51 $ 12.909  Millions$ 8.573  Millions
Treace Medical Concepts Inc   1.50 $ 51.854  Millions$ 34.491  Millions
Intelligent Bio Solutions Inc   1.49 $ 6.862  Millions$ 4.611  Millions
Escalon Medical Corp   1.47 $ 3.343  Millions$ 2.266  Millions
Envista Holdings Corporation  1.38 $ 1,082.800  Millions$ 786.600  Millions
Qhslab Inc   1.32 $ 0.362  Millions$ 0.275  Millions
Globus Medical Inc   1.31 $ 629.851  Millions$ 482.463  Millions
Carlisle Companies Incorporated  1.28 $ 771.300  Millions$ 601.300  Millions
Alphatec Holdings Inc   1.25 $ 139.912  Millions$ 111.566  Millions
Resmed Inc   1.23 $ 1,660.513  Millions$ 1,351.210  Millions
Vicarious Surgical Inc  1.10 $ 3.682  Millions$ 3.348  Millions
Orthopediatrics Corp  1.10 $ 48.809  Millions$ 44.425  Millions
Precision Optics Corporation Inc   1.05 $ 10.680  Millions$ 10.193  Millions
Lifeward ltd   1.00 $ 11.422  Millions$ 11.418  Millions
Sanara Medtech Inc   0.99 $ 13.594  Millions$ 13.701  Millions
Koru Medical Systems Inc   0.99 $ 8.768  Millions$ 8.852  Millions
Lucid Diagnostics Inc   0.98 $ 27.876  Millions$ 28.477  Millions
West Pharmaceutical Services Inc   0.90 $ 521.400  Millions$ 580.000  Millions
Medline Inc   0.88 $ 2,236.000  Millions$ 2,536.000  Millions
Stryker Corp  0.87 $ 3,004.000  Millions$ 3,452.000  Millions
Haemonetics Corporation  0.87 $ 245.440  Millions$ 282.599  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  0.86 $ 6.900  Millions$ 8.058  Millions
Neuronetics Inc   0.83 $ 18.964  Millions$ 22.863  Millions
Integra Lifesciences Holdings Corp  0.83 $ 265.502  Millions$ 321.291  Millions
Establishment Labs Holdings Inc   0.82 $ 68.101  Millions$ 83.153  Millions
Lifestance Health Group Inc   0.81 $ 194.797  Millions$ 239.732  Millions

Date modified: 2026-09-26T07:26:15+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.